A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer

Shanshan Zhao, Amy Leonardson, Milan S. Geybels, Andrew S. McDaniel, Ming Yu, Suzanne Kolb, Hong Zong, Kelly Carter, Javed Siddiqui, Anqi Cheng, Jonathan L. Wright, Colin C. Pritchard, Raymond Lance, Dean Troyer, Jian-Bing Fan, Elaine A. Ostrander, James Y. Dai, Scott A. Tomlins, Ziding Feng, Janet L. Stanford*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)1084-1091
Number of pages8
JournalProstate
Volume78
Issue number14
DOIs
Publication statusPublished - 1 Oct 2018

Keywords

  • biomarker validation
  • DNA methylation score
  • metastatic-lethal
  • prognostic
  • prostate cancer
  • GENE-EXPRESSION
  • RISK
  • BIOMARKERS
  • CLASSIFIER

Cite this

Zhao, S., Leonardson, A., Geybels, M. S., McDaniel, A. S., Yu, M., Kolb, S., Zong, H., Carter, K., Siddiqui, J., Cheng, A., Wright, J. L., Pritchard, C. C., Lance, R., Troyer, D., Fan, J-B., Ostrander, E. A., Dai, J. Y., Tomlins, S. A., Feng, Z., & Stanford, J. L. (2018). A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancer. Prostate, 78(14), 1084-1091. https://doi.org/10.1002/pros.23667